Security key
004468500
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV)
CUSIP: 004468500
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 77,580
- Total 13F value
- $506,597
- Share change
- +36,763
- SEC-reported price per share
- $6.53
- Number of holders
- 2
- Value change
- +$240,062
- Number of buys
- 1
- Shares outstanding
- 106,112,800
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
ACHV full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
ACHIEVE LIFE SCIENCES, INC. SEC filings
ACHIEVE LIFE SCIENCES, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004468500
Recent filing periods:
Ownership snapshot
Top reported holders of ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TPG GP A, LLC
Disclosed value leader
TPG GP A, LLC
Comparable rows
15/15
Latest evidence
30 Apr 2026
13D/G
3/4/5
13F
Lead comparable stake: 13%
13D/G row: TPG GP A, LLC
Showing 1-6 of 15 holder rows.
Quick read
TPG GP A, LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TPG GP A, LLC's linked filing trail.
Comparable ownership
Top 5
TPG GP A, LLC
13%
venBio Global Strategic Fund V, L.P.
10%
Paradigm Biocapital Advisors LP
9.2%
Frazier Life Sciences Public Fund...
6.5%
FRANKLIN RESOURCES INC
6.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TPG GP A, LLC |
13D/G
3/4/5
10%+ Owner
|
13%
|
$40,440,170
13,755,160 shares
|
$0 | 17 Apr 2025 |
| venBio Global Strategic Fund V, L.P. |
13D/G
|
10%
|
$31,567,712
10,737,317 shares
|
$0 | 15 Apr 2026 |
| Paradigm Biocapital Advisors LP |
13D/G
|
9.2%
|
$29,116,913
9,903,712 shares
|
$0 | 17 Apr 2026 |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
6.5%
|
$19,479,817
6,625,788 shares
|
$0 | 17 Apr 2026 |
| FRANKLIN RESOURCES INC |
13D/G
13F
Company
|
6.2%
|
$22,801,922
6,369,252 shares
|
+$211 | 30 Apr 2026 |
| Alyeska Investment Group, L.P. |
13D/G
|
5.6%
|
$9,395,574
2,982,722 shares
|
-$6,098,715 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
77,580
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
79
Q2 2026 holders
2
Holder diff
-77
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend